Symbols / SLP Stock $14.91 +5.22% Simulations Plus, Inc.

Healthcare • Health Information Services • United States • NMS
SLP (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Shawn M. O'Connor
Exch · Country NMS · United States
Market Cap 301.26M
Enterprise Value 259.94M
Income -62.79M
Sales 80.53M
FCF (ttm) 17.18M
Book/sh 6.62
Cash/sh 2.07
Employees 212
Insider 10d —
IPO Jun 18, 1997
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 16.18
PEG 9.88
P/S 3.74
P/B 2.25
P/C —
EV/EBITDA 18.62
EV/Sales 3.23
Quick Ratio 5.26
Current Ratio 5.47
Debt/Eq 0.38
LT Debt/Eq —
EPS (ttm) -3.12
EPS next Y 0.92
EPS Growth 46.70%
Revenue Growth 8.30%
EPS Gr Q/Q 47.50%
Rev Gr Q/Q —
Earnings (next) 2026-04-09
Earnings (prior) 2026-04-09
ROA 3.81%
ROE -38.84%
ROIC —
Gross Margin 61.97%
Oper. Margin 23.18%
Profit Margin -77.96%
Shs Outstand 20.21M
Shs Float 16.70M
Insider Own 17.26%
Instit Own 83.52%
Short Float 8.60%
Short Ratio 3.63
Short Interest 1.23M
52W High 34.01
vs 52W High -56.16%
52W Low 11.09
vs 52W Low 34.45%
Beta 1.19
Impl. Vol. 68.75%
Rel Volume 0.52
Avg Volume 335.67K
Volume 175.40K
Target (mean) $23.67
Tgt Median $24.00
Tgt Low $16.00
Tgt High $31.00
# Analysts 3
Recom Buy
Prev Close $14.17
Price $14.91
Change 5.22%
About

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$23.67
Mean price target
2. Current target
$14.91
Latest analyst target
3. DCF / Fair value
$15.31
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$14.91
Low
$16.00
High
$31.00
Mean
$23.67

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-10 main TD Cowen Hold → Hold $16
2026-01-08 main TD Cowen Hold → Hold $19
2025-12-18 down BTIG Buy → Neutral —
2025-09-30 init TD Cowen — → Hold $16
2025-07-15 main Stephens & Co. Overweight → Overweight $20
2025-07-15 down Keybanc Overweight → Sector Weight —
2025-07-14 main Keybanc Overweight → Overweight $25
2025-07-07 main BTIG Buy → Buy $25
2025-06-18 reit JMP Securities Market Perform → Market Perform —
2025-06-13 main Craig-Hallum Buy → Buy $36
2025-04-16 main Keybanc Overweight → Overweight $40
2025-01-24 main Keybanc Overweight → Overweight $37
2025-01-08 main Keybanc Overweight → Overweight $35
2024-11-15 init Stephens & Co. — → Overweight $39
2024-11-06 reit William Blair — → Outperform —
2024-10-24 reit William Blair — → Outperform —
2024-10-24 main BTIG Buy → Buy $50
2024-09-12 reit William Blair — → Outperform —
2024-07-29 init Keybanc — → Overweight $47
2024-07-16 init JMP Securities — → Market Perform —
News
RSS: Latest SLP news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-15 DIBELLA JOHN ANTHONY II Officer — 1,000 $13.37 $13,370
2026-02-06 DIBELLA JOHN ANTHONY II Officer — 10,300 $9.71 $100,013
2026-01-30 WOLTOSZ WALTER S Director and Beneficial Owner of more than 10% of a Class of Security — 1,776 $0.00 $0
2026-01-30 WEINER DANIEL LEE Director — 1,776 $0.00 $0
2026-01-30 EVANS SHARLENE Director — 1,776 $0.00 $0
2026-01-30 PAGLIA JOHN KENNETH Director — 1,776 $0.00 $0
2026-01-28 FIEDLER-KELLY JILL Officer — 8,950 $9.71 $86,904
2025-12-18 WOLTOSZ WALTER S Director and Beneficial Owner of more than 10% of a Class of Security — 9,095 $0.00 $0
2025-12-01 LAVANGE LISA PH.D. Director — 866 $16.91 $14,644
2025-11-03 WOLTOSZ WALTER S Director and Beneficial Owner of more than 10% of a Class of Security — 1,771 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-08-31 2024-08-31 2023-08-31 2022-08-31
Total Revenue
79.18
+13.09%
70.01
+17.52%
59.58
+10.52%
53.91
Operating Revenue
79.18
+13.09%
70.01
+17.52%
59.58
+10.52%
53.91
Cost Of Revenue
32.96
+22.69%
26.86
+130.97%
11.63
+7.47%
10.82
Reconciled Cost Of Revenue
32.96
+22.69%
26.86
+130.97%
11.63
+7.47%
10.82
Gross Profit
46.22
+7.11%
43.15
-10.00%
47.95
+11.29%
43.08
Operating Expense
39.73
+7.32%
37.02
-4.40%
38.72
+37.44%
28.17
Research And Development
6.88
+19.64%
5.75
+27.75%
4.50
+40.40%
3.21
Selling General And Administration
32.84
+5.05%
31.27
-8.63%
34.22
+37.06%
24.96
Selling And Marketing Expense
11.90
+33.53%
8.91
+35.94%
6.56
+34.41%
4.88
General And Administrative Expense
20.94
-6.31%
22.35
-19.19%
27.66
+37.71%
20.09
Other Gand A
20.94
-6.31%
22.35
-19.19%
27.66
+37.71%
20.09
Total Expenses
72.69
+13.78%
63.88
+26.87%
50.35
+29.12%
38.99
Operating Income
6.49
+5.89%
6.13
-33.54%
9.22
-38.13%
14.91
Total Operating Income As Reported
-70.73
-1253.63%
6.13
-29.73%
8.72
-41.49%
14.91
EBITDA
14.70
+24.64%
11.80
-9.71%
13.06
-29.32%
18.48
Normalized EBITDA
91.29
+823.00%
9.89
-32.83%
14.73
-22.49%
19.00
Reconciled Depreciation
8.21
+44.94%
5.67
+47.53%
3.84
+7.44%
3.57
EBIT
6.49
+5.89%
6.13
-33.54%
9.22
-38.13%
14.91
Total Unusual Items
-76.59
-4120.52%
1.91
+214.69%
-1.66
-223.78%
-0.51
Total Unusual Items Excluding Goodwill
-76.59
-4120.52%
1.91
+214.69%
-1.66
-223.78%
-0.51
Special Income Charges
-76.60
-4773.83%
1.64
+238.20%
-1.19
-320.57%
-0.28
Restructuring And Mergern Acquisition
-0.64
+60.95%
-1.64
-341.03%
0.68
+140.28%
0.28
Write Off
77.22
0.00
-100.00%
0.50
—
Net Income
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Pretax Income
-69.38
-659.00%
12.41
+6.12%
11.70
-22.63%
15.12
Net Non Operating Interest Income Expense
0.72
-83.50%
4.38
+5.91%
4.13
+476.15%
0.72
Interest Expense Non Operating
—
—
0.00
0.00
Net Interest Income
0.72
-83.50%
4.38
+5.91%
4.13
+476.15%
0.72
Interest Expense
—
—
0.00
0.00
Interest Income Non Operating
0.72
-83.50%
4.38
+5.91%
4.13
+476.15%
0.72
Interest Income
0.72
-83.50%
4.38
+5.91%
4.13
+476.15%
0.72
Other Income Expense
-76.59
-4120.52%
1.91
+214.69%
-1.66
-223.78%
-0.51
Gain On Sale Of Security
0.01
-95.11%
0.27
+156.00%
-0.47
-105.63%
-0.23
Tax Provision
-4.66
-289.62%
2.46
+41.70%
1.73
-34.12%
2.63
Tax Rate For Calcs
0.00
-66.16%
0.00
+33.78%
0.00
-12.94%
0.00
Tax Effect Of Unusual Items
-5.13
-1460.48%
0.38
+253.44%
-0.25
-181.88%
-0.09
Net Income Including Noncontrolling Interests
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Net Income From Continuing Operation Net Minority Interest
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Net Income From Continuing And Discontinued Operation
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Net Income Continuous Operations
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Normalized Income
6.74
-19.99%
8.43
-25.93%
11.38
-11.87%
12.91
Net Income Common Stockholders
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Diluted EPS
-3.22
-757.14%
0.49
+0.00%
0.49
-18.33%
0.60
Basic EPS
-3.22
-744.00%
0.50
+0.00%
0.50
-19.35%
0.62
Basic Average Shares
20.10
+0.57%
19.99
-0.44%
20.07
-0.60%
20.20
Diluted Average Shares
20.10
-0.99%
20.30
-0.80%
20.46
-1.37%
20.75
Diluted NI Availto Com Stockholders
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Gain On Sale Of PPE
-0.02
0.00
+100.00%
-0.01
-700.00%
0.00
Line Item Trend 2025-08-31 2024-08-31 2023-08-31 2022-08-31
Total Assets
131.94
-32.90%
196.64
+5.66%
186.10
-1.21%
188.38
Current Assets
51.55
+31.03%
39.34
-69.82%
130.37
-11.18%
146.79
Cash Cash Equivalents And Short Term Investments
32.35
+59.73%
20.25
-82.46%
115.46
-9.96%
128.24
Cash And Cash Equivalents
30.85
+199.22%
10.31
-82.07%
57.52
+11.55%
51.57
Other Short Term Investments
1.50
-84.92%
9.94
-82.84%
57.94
-24.43%
76.67
Receivables
9.72
+6.36%
9.14
-10.44%
10.20
-26.01%
13.79
Accounts Receivable
9.72
+6.36%
9.14
-10.44%
10.20
-26.01%
13.79
Gross Accounts Receivable
9.90
+6.67%
9.29
-9.39%
10.25
-25.74%
13.80
Allowance For Doubtful Accounts Receivable
-0.19
-25.50%
-0.15
-223.91%
-0.05
-283.33%
-0.01
Other Receivables
—
—
—
—
Prepaid Assets
1.78
-19.12%
2.20
+173.26%
0.80
-42.20%
1.39
Other Current Assets
7.70
-0.66%
7.75
+98.59%
3.90
+15.61%
3.38
Total Non Current Assets
80.39
-48.90%
157.30
+182.26%
55.73
+33.99%
41.59
Net PPE
1.29
-30.02%
1.84
-4.12%
1.92
-6.53%
2.05
Gross PPE
1.86
-23.67%
2.44
-5.28%
2.58
-4.52%
2.70
Accumulated Depreciation
-0.58
+4.31%
-0.60
+8.64%
-0.66
-1.85%
-0.65
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.44
+8.28%
1.33
+54.96%
0.86
-6.95%
0.92
Construction In Progress
0.00
0.00
-100.00%
0.13
0.00
Other Properties
0.42
-61.97%
1.09
-30.01%
1.56
-11.49%
1.77
Leases
0.01
-50.00%
0.02
-16.67%
0.02
+84.62%
0.01
Goodwill And Other Intangible Assets
72.93
-52.93%
154.92
+198.22%
51.95
+32.86%
39.10
Goodwill
43.72
-54.50%
96.08
+403.05%
19.10
+47.81%
12.92
Other Intangible Assets
29.21
-50.36%
58.84
+79.12%
32.85
+25.47%
26.18
Non Current Deferred Assets
4.77
0.00
-100.00%
1.44
0.00
Non Current Deferred Taxes Assets
4.77
0.00
-100.00%
1.44
0.00
Other Non Current Assets
1.40
+158.12%
0.54
+27.53%
0.42
-3.19%
0.44
Total Liabilities Net Minority Interest
7.13
-49.78%
14.21
-11.60%
16.07
+58.59%
10.13
Current Liabilities
6.72
-44.28%
12.07
+0.68%
11.99
+54.97%
7.74
Payables And Accrued Expenses
1.81
-64.35%
5.08
+25.46%
4.05
+250.61%
1.16
Payables
0.47
-84.55%
3.04
-10.37%
3.39
+1408.44%
0.23
Accounts Payable
0.47
-21.93%
0.60
+318.06%
0.14
-36.00%
0.23
Other Payable
—
2.44
-24.92%
3.25
—
Current Accrued Expenses
1.34
-34.26%
2.04
+210.02%
0.66
-29.22%
0.93
Pensionand Other Post Retirement Benefit Plans Current
2.01
-55.46%
4.51
+2.76%
4.39
+34.97%
3.25
Current Debt And Capital Lease Obligation
0.21
-56.63%
0.47
+7.47%
0.44
-4.12%
0.46
Current Capital Lease Obligation
0.21
-56.63%
0.47
+7.47%
0.44
-4.12%
0.46
Current Deferred Liabilities
2.70
+35.07%
2.00
-35.61%
3.10
+8.24%
2.86
Current Deferred Revenue
2.70
+35.07%
2.00
-35.61%
3.10
+8.24%
2.86
Total Non Current Liabilities Net Minority Interest
0.41
-80.83%
2.14
-47.64%
4.08
+70.28%
2.40
Long Term Debt And Capital Lease Obligation
0.41
-22.79%
0.53
-29.67%
0.76
-19.94%
0.94
Long Term Capital Lease Obligation
0.41
-22.79%
0.53
-29.67%
0.76
-19.94%
0.94
Tradeand Other Payables Non Current
—
0.00
-100.00%
3.33
0.00
Non Current Deferred Liabilities
0.00
-100.00%
1.61
0.00
-100.00%
1.46
Non Current Deferred Taxes Liabilities
0.00
-100.00%
1.61
0.00
-100.00%
1.46
Stockholders Equity
124.80
-31.59%
182.43
+7.29%
170.03
-4.61%
178.25
Common Stock Equity
124.80
-31.59%
182.43
+7.29%
170.03
-4.61%
178.25
Capital Stock
0.02
+0.00%
0.02
-99.99%
144.97
+4.67%
138.51
Common Stock
0.02
+0.00%
0.02
-99.99%
144.97
+4.67%
138.51
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
20.14
+0.43%
20.05
+0.57%
19.94
-1.59%
20.26
Ordinary Shares Number
20.14
+0.43%
20.05
+0.57%
19.94
-1.59%
20.26
Additional Paid In Capital
159.42
+4.67%
152.31
—
—
Retained Earnings
-34.36
-213.21%
30.35
+20.47%
25.20
-37.08%
40.04
Gains Losses Not Affecting Retained Earnings
-0.27
-7.97%
-0.25
-78.01%
-0.14
+54.22%
-0.31
Other Equity Adjustments
-0.27
-7.97%
-0.25
-78.01%
-0.14
+54.22%
-0.31
Total Equity Gross Minority Interest
124.80
-31.59%
182.43
+7.29%
170.03
-4.61%
178.25
Total Capitalization
124.80
-31.59%
182.43
+7.29%
170.03
-4.61%
178.25
Working Capital
44.82
+64.36%
27.27
-76.96%
118.39
-14.86%
139.06
Invested Capital
124.80
-31.59%
182.43
+7.29%
170.03
-4.61%
178.25
Total Debt
0.62
-38.77%
1.01
-15.96%
1.20
-14.74%
1.40
Capital Lease Obligations
0.62
-38.77%
1.01
-15.96%
1.20
-14.74%
1.40
Net Tangible Assets
51.87
+88.54%
27.51
-76.70%
118.08
-15.14%
139.15
Tangible Book Value
51.87
+88.54%
27.51
-76.70%
118.08
-15.14%
139.15
Line Item Trend 2025-08-31 2024-08-31 2023-08-31 2022-08-31
Operating Cash Flow
18.13
+36.08%
13.32
-39.06%
21.86
+22.10%
17.90
Cash Flow From Continuing Operating Activities
18.13
+36.08%
13.32
-39.06%
21.86
+22.10%
17.90
Net Income From Continuing Operations
-64.72
-750.17%
9.95
-0.07%
9.96
-20.20%
12.48
Depreciation Amortization Depletion
8.21
+44.94%
5.67
+47.53%
3.84
+7.44%
3.57
Depreciation And Amortization
8.21
+44.94%
5.67
+47.53%
3.84
+7.44%
3.57
Other Non Cash Items
-0.86
+47.28%
-1.64
-341.03%
0.68
+140.28%
0.28
Stock Based Compensation
6.35
-2.81%
6.54
+35.42%
4.83
+58.97%
3.04
Asset Impairment Charge
77.22
0.00
-100.00%
0.50
0.00
Deferred Tax
-5.43
-207.42%
-1.76
+15.75%
-2.10
-675.93%
-0.27
Deferred Income Tax
-5.43
-207.42%
-1.76
+15.75%
-2.10
-675.93%
-0.27
Operating Gains Losses
-0.00
+98.10%
-0.10
-160.69%
0.17
+165.28%
-0.27
Net Foreign Currency Exchange Gain Loss
-0.03
+76.19%
-0.10
-162.87%
0.17
+163.02%
-0.27
Change In Working Capital
-2.59
+38.60%
-4.21
-182.54%
5.10
+294.77%
-2.62
Change In Receivables
-0.58
-118.57%
3.13
-23.63%
4.10
+204.09%
-3.94
Changes In Account Receivables
-0.58
-118.57%
3.13
-23.63%
4.10
+204.09%
-3.94
Change In Prepaid Assets
0.61
+117.36%
-3.54
-4211.63%
0.09
-87.75%
0.70
Change In Payables And Accrued Expense
-0.13
+72.33%
-0.48
-442.05%
-0.09
+45.68%
-0.16
Change In Accrued Expense
—
—
—
—
Change In Payable
-0.13
+72.33%
-0.48
-442.05%
-0.09
+45.68%
-0.16
Change In Account Payable
-0.13
+72.33%
-0.48
-488.89%
-0.08
+50.00%
-0.16
Change In Other Working Capital
0.70
+127.34%
-2.56
-1554.55%
0.18
-92.05%
2.21
Change In Other Current Liabilities
-3.19
-314.97%
-0.77
-192.31%
0.83
+157.90%
-1.44
Investing Cash Flow
3.56
+106.60%
-53.97
-832.65%
7.37
+71.10%
4.30
Cash Flow From Continuing Investing Activities
3.56
+106.60%
-53.97
-832.65%
7.37
+71.10%
4.30
Net PPE Purchase And Sale
-0.71
-25.97%
-0.57
-24.94%
-0.45
+44.69%
-0.82
Purchase Of PPE
-0.71
-25.97%
-0.57
-24.94%
-0.45
+44.69%
-0.82
Capital Expenditure
-3.72
+13.44%
-4.30
-0.66%
-4.27
-7.63%
-3.97
Capital Expenditure Reported
-2.63
+17.63%
-3.19
+0.78%
-3.22
-2.16%
-3.15
Net Investment Purchase And Sale
8.51
-82.67%
49.11
+147.24%
19.86
+140.02%
8.28
Purchase Of Investment
-6.50
+90.32%
-67.16
+29.34%
-95.05
+5.75%
-100.85
Sale Of Investment
15.01
-87.09%
116.27
+1.18%
114.91
+5.30%
109.12
Net Business Purchase And Sale
0.00
+100.00%
-98.77
-1101.18%
-8.22
0.00
Purchase Of Business
0.00
+100.00%
-98.77
-1101.18%
-8.22
0.00
Net Intangibles Purchase And Sale
-0.38
+29.94%
-0.54
+9.98%
-0.60
0.00
Purchase Of Intangibles
-0.38
+29.94%
-0.54
+9.98%
-0.60
0.00
Net Other Investing Changes
-1.23
—
—
—
Financing Cash Flow
-1.15
+82.54%
-6.57
+71.78%
-23.27
-205.25%
-7.62
Cash Flow From Continuing Financing Activities
-1.15
+82.54%
-6.57
+71.78%
-23.27
-205.25%
-7.62
Net Common Stock Issuance
0.00
0.00
+100.00%
-20.00
0.00
Common Stock Payments
0.00
0.00
+100.00%
-20.00
0.00
Common Stock Dividend Paid
0.00
+100.00%
-4.80
+0.27%
-4.81
+0.76%
-4.85
Cash Dividends Paid
0.00
+100.00%
-4.80
+0.27%
-4.81
+0.76%
-4.85
Repurchase Of Capital Stock
0.00
0.00
+100.00%
-20.00
0.00
Proceeds From Stock Option Exercised
0.43
-41.18%
0.73
-52.62%
1.54
+73.18%
0.89
Net Other Financing Charges
-1.58
+36.96%
-2.50
—
-3.67
Changes In Cash
20.54
+143.51%
-47.21
-892.68%
5.96
-59.16%
14.58
Beginning Cash Position
10.31
-82.07%
57.52
+11.55%
51.57
+39.43%
36.98
End Cash Position
30.85
+199.22%
10.31
-82.07%
57.52
+11.55%
51.57
Free Cash Flow
14.40
+59.70%
9.02
-48.71%
17.58
+26.22%
13.93
Income Tax Paid Supplemental Data
1.16
-79.61%
5.69
+77.56%
3.20
-0.90%
3.23
Amortization Of Securities
-0.06
+94.27%
-1.12
+1.59%
-1.13
-167.58%
1.68
Change In Income Tax Payable
0.00
0.00
+100.00%
-0.01
0.00
Change In Tax Payable
0.00
0.00
+100.00%
-0.01
0.00
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
Sale Of Business
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category